ESTRADIOL

ESTRADIOL was reported 86535 times

These side effects are most commonly reported by patients taking ESTRADIOL:

# Side effect Count
0 DRUG INEFFECTIVE 8129
1 PRODUCT ADHESION ISSUE 6148
2 HEADACHE 5211
3 NAUSEA 4980
4 FATIGUE 4832
5 OFF LABEL USE 4799
6 PAIN 3673
7 HOT FLUSH 3474
8 DIARRHOEA 3268
9 DIZZINESS 3098
10 ARTHRALGIA 3019
11 RASH 2673
12 PRURITUS 2619
13 PRODUCT QUALITY ISSUE 2609
14 DYSPNOEA 2581
15 INSOMNIA 2567
16 BREAST CANCER FEMALE 2437
17 MALAISE 2426
18 NO ADVERSE EVENT 2377
19 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2345
20 ANXIETY 2271
21 VOMITING 2185
22 FEELING ABNORMAL 2155
23 PAIN IN EXTREMITY 2015
24 DEPRESSION 1888
25 BREAST CANCER 1881
26 ASTHENIA 1837
27 WEIGHT INCREASED 1833
28 PRODUCT DOSE OMISSION ISSUE 1775
29 BACK PAIN 1720
30 FALL 1718
31 WEIGHT DECREASED 1659
32 APPLICATION SITE PRURITUS 1651
33 APPLICATION SITE ERYTHEMA 1640
34 ALOPECIA 1639
35 URINARY TRACT INFECTION 1620
36 MUSCLE SPASMS 1575
37 CONDITION AGGRAVATED 1557
38 COUGH 1535
39 MIGRAINE 1460
40 PRODUCT USE ISSUE 1422
41 ABDOMINAL PAIN 1419
42 DEVICE ADHESION ISSUE 1410
43 APPLICATION SITE RASH 1333
44 CONSTIPATION 1301
45 HYPERSENSITIVITY 1285
46 PRODUCT SUBSTITUTION ISSUE 1273
47 PRODUCT USE IN UNAPPROVED INDICATION 1273
48 ABDOMINAL PAIN UPPER 1270
49 SINUSITIS 1239
50 DRUG HYPERSENSITIVITY 1223
51 PNEUMONIA 1220
52 PYREXIA 1217
53 INJECTION SITE PAIN 1207
54 INCORRECT DOSE ADMINISTERED 1197
55 HYPERTENSION 1171
56 PARAESTHESIA 1140
57 HYPERHIDROSIS 1136
58 URTICARIA 1125
59 PALPITATIONS 1121
60 CHEST PAIN 1108
61 GAIT DISTURBANCE 1103
62 BLOOD PRESSURE INCREASED 1099
63 NASOPHARYNGITIS 1088
64 ABDOMINAL DISCOMFORT 1080
65 MYALGIA 1078
66 ABDOMINAL DISTENSION 1075
67 PERIPHERAL SWELLING 1054
68 COVID-19 1045
69 ERYTHEMA 1033
70 HYPOAESTHESIA 966
71 TREMOR 957
72 VAGINAL HAEMORRHAGE 937
73 APPLICATION SITE IRRITATION 925
74 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 923
75 SOMNOLENCE 923
76 VISION BLURRED 906
77 MEMORY IMPAIRMENT 903
78 DECREASED APPETITE 881
79 NIGHT SWEATS 869
80 JOINT SWELLING 855
81 DRUG INTERACTION 836
82 BRONCHITIS 821
83 ARTHRITIS 818
84 DRUG DOSE OMISSION 814
85 GASTROOESOPHAGEAL REFLUX DISEASE 800
86 INFECTION 764
87 VULVOVAGINAL DISCOMFORT 759
88 CONTUSION 752
89 APPLICATION SITE PAIN 735
90 ASTHMA 728
91 RHEUMATOID ARTHRITIS 725
92 DEVICE MALFUNCTION 716
93 DYSPEPSIA 713
94 CHEST DISCOMFORT 699
95 HEART RATE INCREASED 697
96 OEDEMA PERIPHERAL 687
97 ILLNESS 685
98 MUSCULAR WEAKNESS 685
99 ANAEMIA 682
100 OROPHARYNGEAL PAIN 681
101 FLUSHING 664
102 CHILLS 657
103 BURNING SENSATION 652
104 CONFUSIONAL STATE 649
105 DRY MOUTH 643
106 HYPOTENSION 632
107 CHRONIC KIDNEY DISEASE 631
108 STRESS 628
109 DEVICE ISSUE 627
110 INFLUENZA 626
111 BALANCE DISORDER 624
112 SLEEP DISORDER 614
113 VISUAL IMPAIRMENT 614
114 DRUG INTOLERANCE 612
115 SWELLING 605
116 FUNGAL INFECTION 601
117 EYE PAIN 595
118 VULVOVAGINAL BURNING SENSATION 594
119 SUICIDAL IDEATION 592
120 PRODUCT PACKAGING ISSUE 586
121 DEHYDRATION 585
122 INJECTION SITE ERYTHEMA 579
123 DEATH 574
124 FEELING HOT 569
125 DRY SKIN 568
126 ACUTE KIDNEY INJURY 564
127 CEREBROVASCULAR ACCIDENT 562
128 INFLUENZA LIKE ILLNESS 562
129 DRY EYE 555
130 HERPES ZOSTER 548
131 DISCOMFORT 542
132 OSTEOARTHRITIS 540
133 BLOOD CHOLESTEROL INCREASED 539
134 IRRITABILITY 531
135 NECK PAIN 530
136 PSORIASIS 528
137 INTENTIONAL PRODUCT USE ISSUE 525
138 FIBROMYALGIA 520
139 NEUROPATHY PERIPHERAL 504
140 LOSS OF CONSCIOUSNESS 501
141 RENAL FAILURE 497
142 MENOPAUSAL SYMPTOMS 490
143 PULMONARY EMBOLISM 483
144 WRONG TECHNIQUE IN DRUG USAGE PROCESS 483
145 OSTEOPOROSIS 482
146 EYE IRRITATION 476
147 MUSCULOSKELETAL STIFFNESS 475
148 GASTROINTESTINAL DISORDER 471
149 BREAST TENDERNESS 465
150 VULVOVAGINAL PAIN 454
151 VERTIGO 452
152 DEPRESSED MOOD 445
153 AMNESIA 437
154 TINNITUS 437
155 PRODUCT PHYSICAL ISSUE 436
156 SWELLING FACE 434
157 HAEMORRHAGE 428
158 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 424
159 UPPER RESPIRATORY TRACT INFECTION 420
160 NERVOUSNESS 419
161 THERAPEUTIC RESPONSE UNEXPECTED 419
162 DYSGEUSIA 418
163 DRUG EFFECT DECREASED 417
164 DYSPHAGIA 414
165 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 414
166 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 412
167 VAGINAL DISCHARGE 412
168 HEPATIC ENZYME INCREASED 411
169 CYSTITIS 409
170 RHINORRHOEA 409
171 BONE PAIN 408
172 UNDERDOSE 408
173 MOOD SWINGS 406
174 SURGERY 404
175 BLISTER 403
176 ADVERSE DRUG REACTION 400
177 INTENTIONAL PRODUCT MISUSE 400
178 SYNCOPE 394
179 CRYING 393
180 DYSPHONIA 390
181 MYOCARDIAL INFARCTION 389
182 BLOOD GLUCOSE INCREASED 387
183 ATRIAL FIBRILLATION 386
184 PRODUCT DOSE OMISSION 386
185 THERAPY CESSATION 383
186 UNEVALUABLE EVENT 379
187 INJECTION SITE BRUISING 378
188 FLATULENCE 377
189 DISEASE RECURRENCE 376
190 SKIN IRRITATION 376
191 DISTURBANCE IN ATTENTION 375
192 NASAL CONGESTION 375
193 RASH PRURITIC 374
194 VULVOVAGINAL DRYNESS 361
195 CATARACT 360
196 MUSCULOSKELETAL PAIN 356
197 THERAPEUTIC PRODUCT EFFECT DECREASED 355
198 VULVOVAGINAL PRURITUS 350
199 HAEMOGLOBIN DECREASED 344
200 FLUID RETENTION 343
201 DIVERTICULITIS 342
202 INJECTION SITE PRURITUS 339
203 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 338
204 DEEP VEIN THROMBOSIS 337
205 DEVICE DIFFICULT TO USE 336
206 ARTHROPATHY 335
207 OVERDOSE 335
208 SKIN EXFOLIATION 335
209 ADVERSE EVENT 333
210 PRODUCT AVAILABILITY ISSUE 333
211 EMOTIONAL DISTRESS 331
212 SYNOVITIS 327
213 BREAST PAIN 326
214 DRUG PRESCRIBING ERROR 326
215 LETHARGY 325
216 TACHYCARDIA 324
217 POLLAKIURIA 322
218 WHITE BLOOD CELL COUNT DECREASED 319
219 NEPHROLITHIASIS 316
220 THROMBOSIS 316
221 ECZEMA 314
222 INFUSION RELATED REACTION 314
223 RASH ERYTHEMATOUS 314
224 SEIZURE 314
225 AGITATION 312
226 MOBILITY DECREASED 307
227 TREATMENT FAILURE 306
228 WHEEZING 305
229 OEDEMA 300
230 URINARY INCONTINENCE 300
231 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 299
232 POOR QUALITY SLEEP 294
233 INJECTION SITE SWELLING 292
234 PRODUCT PACKAGING QUANTITY ISSUE 292
235 CARDIAC DISORDER 291
236 GENERAL PHYSICAL HEALTH DETERIORATION 291
237 HALLUCINATION 291
238 APPLICATION SITE VESICLES 290
239 DERMATITIS CONTACT 290
240 STOMATITIS 290
241 MENINGIOMA 288
242 PANIC ATTACK 288
243 SKIN BURNING SENSATION 287
244 PRODUCT USE COMPLAINT 286
245 DIABETES MELLITUS 285
246 MATERNAL EXPOSURE DURING PREGNANCY 284
247 SLEEP APNOEA SYNDROME 283
248 MULTIPLE SCLEROSIS RELAPSE 282
249 PHARMACEUTICAL PRODUCT COMPLAINT 282
250 LIVER FUNCTION TEST ABNORMAL 281
251 ACNE 280
252 CROHN^S DISEASE 280
253 INFLAMMATION 280
254 THERAPY INTERRUPTED 280
255 EPISTAXIS 278
256 INJURY 278
257 HORMONE LEVEL ABNORMAL 277
258 APPLICATION SITE REACTION 275
259 SPEECH DISORDER 271
260 LIMB DISCOMFORT 270
261 HOSPITALISATION 269
262 SKIN DISCOLOURATION 269
263 THROAT IRRITATION 269
264 HYSTERECTOMY 267
265 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 266
266 INJECTION SITE REACTION 265
267 MOOD ALTERED 264
268 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 262
269 LIP SWELLING 260
270 CELLULITIS 259
271 COGNITIVE DISORDER 259
272 DYSURIA 259
273 IRRITABLE BOWEL SYNDROME 259
274 LEUKOPENIA 258
275 OSTEOPENIA 258
276 PRODUCTIVE COUGH 255
277 INCORRECT DRUG ADMINISTRATION DURATION 254
278 OCULAR HYPERAEMIA 254
279 ROAD TRAFFIC ACCIDENT 254
280 EYE SWELLING 252
281 C-REACTIVE PROTEIN INCREASED 251
282 CARDIAC FAILURE CONGESTIVE 248
283 BLOOD OESTROGEN DECREASED 247
284 BLOOD POTASSIUM DECREASED 247
285 ORAL PAIN 247
286 PSORIATIC ARTHROPATHY 247
287 TRANSIENT ISCHAEMIC ATTACK 247
288 VULVOVAGINAL MYCOTIC INFECTION 245
289 ILL-DEFINED DISORDER 243
290 LYMPHADENOPATHY 242
291 VAGINAL INFECTION 241
292 ACCIDENTAL EXPOSURE TO PRODUCT 240
293 ELECTROCARDIOGRAM QT PROLONGED 240
294 EMOTIONAL DISORDER 239
295 HEART RATE DECREASED 239
296 PRODUCT STORAGE ERROR 239
297 DYSPNOEA EXERTIONAL 236
298 FEELING COLD 236
299 POSTMENOPAUSAL HAEMORRHAGE 234
300 BLOOD PRESSURE DECREASED 232
301 DERMATITIS ATOPIC 232
302 DEVICE USE ISSUE 232
303 TOXICITY TO VARIOUS AGENTS 232
304 WITHDRAWAL SYNDROME 232
305 METRORRHAGIA 231
306 CONTRAINDICATED PRODUCT ADMINISTERED 230
307 MULTIPLE SCLEROSIS 230
308 CHOLELITHIASIS 229
309 OXYGEN SATURATION DECREASED 229
310 THYROID DISORDER 229
311 SEPSIS 228
312 DEVICE DEFECTIVE 227
313 PAIN IN JAW 226
314 INJECTION SITE HAEMORRHAGE 223
315 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 221
316 EXPIRED PRODUCT ADMINISTERED 221
317 NEURALGIA 220
318 INCORRECT DOSE ADMINISTERED BY DEVICE 219
319 ORAL HERPES 219
320 PLATELET COUNT DECREASED 219
321 TREATMENT NONCOMPLIANCE 219
322 ANGER 217
323 BRAIN FOG 217
324 BREAST CANCER METASTATIC 217
325 VIRAL INFECTION 217
326 PANCREATITIS 215
327 APPLICATION SITE BURN 214
328 BLOOD PRESSURE SYSTOLIC INCREASED 214
329 SKIN REACTION 214
330 ANAPHYLACTIC REACTION 213
331 PRODUCT PRESCRIBING ERROR 213
332 SKIN DISORDER 213
333 SWOLLEN TONGUE 213
334 HYPOTHYROIDISM 211
335 DRUG LEVEL INCREASED 210
336 NIGHTMARE 210
337 IMPAIRED HEALING 209
338 MEDICATION ERROR 209
339 MIDDLE INSOMNIA 209
340 RASH MACULAR 209
341 RASH PAPULAR 209
342 THERAPEUTIC RESPONSE DECREASED 209
343 PRODUCT ADMINISTRATION ERROR 207
344 RENAL IMPAIRMENT 207
345 DISORIENTATION 206
346 GLAUCOMA 206
347 INTERVERTEBRAL DISC PROTRUSION 206
348 LIMB INJURY 205
349 SEASONAL ALLERGY 205
350 LOWER RESPIRATORY TRACT INFECTION 204
351 RESTLESS LEGS SYNDROME 204
352 HYPOACUSIS 203
353 SYSTEMIC LUPUS ERYTHEMATOSUS 203
354 DRUG WITHDRAWAL SYNDROME 200
355 HEAD INJURY 200
356 WHITE BLOOD CELL COUNT INCREASED 198
357 ABDOMINAL PAIN LOWER 197
358 APPLICATION SITE SWELLING 197
359 CANDIDA INFECTION 196
360 GASTRITIS 196
361 ABORTION SPONTANEOUS 195
362 APPLICATION SITE URTICARIA 195
363 FOOT FRACTURE 195
364 GAIT INABILITY 194
365 LACRIMATION INCREASED 194
366 GASTRIC DISORDER 190
367 OESTROGEN RECEPTOR ASSAY POSITIVE 190
368 EAR PAIN 189
369 HAEMATOCHEZIA 189
370 CARPAL TUNNEL SYNDROME 188
371 INTENTIONAL DOSE OMISSION 188
372 RECTAL HAEMORRHAGE 188
373 SCHIZOAFFECTIVE DISORDER 188
374 ALANINE AMINOTRANSFERASE INCREASED 185
375 DRUG EFFECT INCOMPLETE 185
376 DEVICE BREAKAGE 184
377 THERAPY NON-RESPONDER 184
378 EAR INFECTION 183
379 MENTAL DISORDER 183
380 SINUS DISORDER 183
381 BLOOD PRESSURE FLUCTUATION 180
382 DYSKINESIA 180
383 MOVEMENT DISORDER 180
384 COLITIS 179
385 FEELING JITTERY 179
386 INTESTINAL OBSTRUCTION 179
387 DIPLOPIA 178
388 HIATUS HERNIA 177
389 DRUG-INDUCED LIVER INJURY 175
390 HYPONATRAEMIA 175
391 INTERVERTEBRAL DISC DEGENERATION 175
392 PROCEDURAL PAIN 175
393 PELVIC PAIN 174
394 HAEMORRHOIDS 173
395 HYPERSOMNIA 172
396 ARRHYTHMIA 171
397 ABNORMAL DREAMS 170
398 CONVULSION 170
399 RESTLESSNESS 170
400 SCAR 170
401 STAPHYLOCOCCAL INFECTION 170
402 APHASIA 169
403 ASPARTATE AMINOTRANSFERASE INCREASED 169
404 PNEUMONIA VIRAL 169
405 DYSARTHRIA 168
406 HEART RATE IRREGULAR 168
407 TOOTHACHE 168
408 OESTRADIOL DECREASED 167
409 PRE-EXISTING CONDITION IMPROVED 166
410 THROAT TIGHTNESS 166
411 TENDERNESS 165
412 TENDONITIS 164
413 DISEASE PROGRESSION 162
414 EYE PRURITUS 162
415 NEOPLASM MALIGNANT 161
416 NEUTROPENIA 161
417 SCIATICA 161
418 COLITIS MICROSCOPIC 160
419 DEPRESSED LEVEL OF CONSCIOUSNESS 160
420 IMPAIRED GASTRIC EMPTYING 160
421 SPINAL OSTEOARTHRITIS 160
422 FEMUR FRACTURE 159
423 BURSITIS 158
424 DRUG ADMINISTRATION ERROR 158
425 HYPOKALAEMIA 158
426 OVARIAN CANCER 158
427 PRODUCT DOSE OMISSION IN ERROR 158
428 EYE DISORDER 157
429 INJECTION SITE RASH 157
430 KIDNEY INFECTION 157
431 PHOTOPHOBIA 157
432 PRODUCT SIZE ISSUE 156
433 PROGESTERONE RECEPTOR ASSAY POSITIVE 156
434 BREAST CANCER IN SITU 155
435 RESPIRATORY TRACT INFECTION 155
436 APPLICATION SITE DISCOLOURATION 154
437 GASTROINTESTINAL HAEMORRHAGE 154
438 INTERMENSTRUAL BLEEDING 154
439 MUSCULOSKELETAL DISCOMFORT 154
440 ROTATOR CUFF SYNDROME 153
441 MENTAL IMPAIRMENT 152
442 BLOOD PRESSURE ABNORMAL 150
443 IMPAIRED WORK ABILITY 150
444 KNEE ARTHROPLASTY 149
445 PLEURAL EFFUSION 149
446 PRURITUS GENERALISED 148
447 BREAST MASS 147
448 PRODUCT ADMINISTRATION INTERRUPTED 147
449 PRODUCT PRESCRIBING ISSUE 147
450 BONE DISORDER 146
451 DYSSTASIA 146
452 BLOOD CREATININE INCREASED 145
453 JOINT STIFFNESS 145
454 MICTURITION URGENCY 145
455 THERAPEUTIC RESPONSE SHORTENED 145
456 THROMBOCYTOPENIA 144
457 BLINDNESS 143
458 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 143
459 INFUSION SITE PAIN 143
460 LUNG DISORDER 143
461 SUICIDE ATTEMPT 143
462 COLITIS ULCERATIVE 142
463 CHROMATURIA 141
464 LOCALISED INFECTION 140
465 PRESYNCOPE 140
466 RENAL DISORDER 140
467 FREQUENT BOWEL MOVEMENTS 139
468 PHOTOSENSITIVITY REACTION 139
469 TOOTH DISORDER 139
470 HIP FRACTURE 138
471 JOINT INJURY 138
472 THINKING ABNORMAL 138
473 URINARY RETENTION 137
474 VITAMIN D DEFICIENCY 137
475 POOR QUALITY PRODUCT ADMINISTERED 136
476 SYMPTOM RECURRENCE 136
477 INSURANCE ISSUE 135
478 POST PROCEDURAL COMPLICATION 135
479 INJECTION SITE MASS 134
480 INJECTION SITE URTICARIA 134
481 RENAL INJURY 134
482 UTERINE LEIOMYOMA 133
483 ANKLE FRACTURE 132
484 HEAD DISCOMFORT 132
485 MUSCLE TWITCHING 131
486 PARAESTHESIA ORAL 131
487 RED BLOOD CELL COUNT DECREASED 131
488 UPPER LIMB FRACTURE 131
489 DEVICE DELIVERY SYSTEM ISSUE 130
490 PRODUCT RESIDUE PRESENT 130
491 HYPERLIPIDAEMIA 129
492 MUSCLE TIGHTNESS 129
493 TOXIC EPIDERMAL NECROLYSIS 129
494 DIVERTICULUM 128
495 PAIN OF SKIN 128
496 INCORRECT DOSE ADMINISTERED BY PRODUCT 127
497 TYPE 2 DIABETES MELLITUS 127
498 PRODUCT COMPLAINT 126
499 RESPIRATORY DISORDER 126
500 EXPOSURE DURING PREGNANCY 125
501 FEAR 125
502 LIVER DISORDER 125
503 RASH GENERALISED 125
504 AGEUSIA 124
505 SENSORY DISTURBANCE 124
506 ABNORMAL BEHAVIOUR 123
507 AGGRESSION 123
508 ANGINA PECTORIS 123
509 APPLICATION SITE HYPERSENSITIVITY 123
510 DERMATITIS 123
511 DEVICE PHYSICAL PROPERTY ISSUE 123
512 EATING DISORDER 123
513 END STAGE RENAL DISEASE 123
514 ANGIOEDEMA 122
515 GLOSSODYNIA 122
516 SKIN LESION 122
517 SNEEZING 122
518 TOOTH INFECTION 122
519 WOUND 122
520 DYSPAREUNIA 121
521 CLOSTRIDIUM DIFFICILE INFECTION 120
522 PRODUCT DISPENSING ERROR 120
523 RIB FRACTURE 120
524 ACTIVITIES OF DAILY LIVING IMPAIRED 119
525 BLOOD ALKALINE PHOSPHATASE INCREASED 119
526 HEPATIC CIRRHOSIS 119
527 IMPAIRED QUALITY OF LIFE 119
528 OVARIAN CYST 119
529 TRICUSPID VALVE INCOMPETENCE 119
530 BLOOD TRIGLYCERIDES INCREASED 118
531 BONE DENSITY DECREASED 118
532 DRUG DOSE OMISSION BY DEVICE 118
533 SKIN LACERATION 118
534 BODY HEIGHT DECREASED 117
535 EMPHYSEMA 117
536 HAIR TEXTURE ABNORMAL 117
537 APPLICATION SITE SCAR 116
538 BACK DISORDER 116
539 THERAPEUTIC PRODUCT INEFFECTIVE 116
540 DRUG DEPENDENCE 115
541 FAECES DISCOLOURED 115
542 FEEDING DISORDER 115
543 INCORRECT PRODUCT ADMINISTRATION DURATION 115
544 INFUSION SITE ERYTHEMA 115
545 LOWER LIMB FRACTURE 115
546 MUSCULOSKELETAL CHEST PAIN 114
547 DEAFNESS 113
548 PHARYNGEAL OEDEMA 113
549 RESPIRATORY TRACT CONGESTION 113
550 BLADDER DISORDER 112
551 COELIAC DISEASE 112
552 COLD SWEAT 112
553 ECONOMIC PROBLEM 112
554 GASTROENTERITIS 112
555 PRESCRIBED UNDERDOSE 112
556 SOFT TISSUE DISORDER 112
557 BACTERIAL INFECTION 111
558 BREAST ENLARGEMENT 111
559 DRUG EFFECT LESS THAN EXPECTED 111
560 ERUCTATION 111
561 SINUS CONGESTION 111
562 SKIN ULCER 111
563 SPINAL OPERATION 111
564 BLOOD URINE PRESENT 110
565 DISABILITY 110
566 EXOSTOSIS 110
567 GASTROENTERITIS VIRAL 110
568 PRODUCT ODOUR ABNORMAL 110
569 BODY TEMPERATURE INCREASED 109
570 MOUTH ULCERATION 109
571 PULMONARY OEDEMA 109
572 RESPIRATORY FAILURE 109
573 SKIN CANCER 109
574 CORONARY ARTERY DISEASE 108
575 HAEMATOCRIT DECREASED 108
576 TASTE DISORDER 108
577 BRADYCARDIA 107
578 NEEDLE ISSUE 107
579 PSYCHOTIC DISORDER 107
580 CHRONIC SINUSITIS 106
581 MULTIPLE ALLERGIES 106
582 PRESCRIBED OVERDOSE 106
583 RETCHING 106
584 VISUAL ACUITY REDUCED 106
585 BLOOD SODIUM DECREASED 105
586 GALLBLADDER DISORDER 105
587 HAIR GROWTH ABNORMAL 105
588 NERVOUS SYSTEM DISORDER 105
589 THIRST 105
590 VITAMIN D DECREASED 105
591 BASAL CELL CARCINOMA 104
592 PERIPHERAL COLDNESS 104
593 VAGINAL ODOUR 104
594 MENISCUS INJURY 103
595 BLOOD OESTROGEN INCREASED 102
596 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 102
597 HEPATIC STEATOSIS 102
598 HYPOGLYCAEMIA 102
599 PANCREATITIS ACUTE 102
600 WRIST FRACTURE 102
601 COMPLETED SUICIDE 101
602 DEVICE LEAKAGE 101
603 DRUG ADMINISTERED AT INAPPROPRIATE SITE 101
604 INJECTION SITE WARMTH 101
605 ABASIA 100
606 AUTOIMMUNE DISORDER 100
607 CHOKING 100
608 CYST 100
609 INFUSION SITE SWELLING 100
610 LIGAMENT SPRAIN 100
611 LOCAL SWELLING 100
612 ORAL DISCOMFORT 100
613 EXPOSURE VIA SKIN CONTACT 99
614 POOR VENOUS ACCESS 99
615 ADHESIVE TAPE USE 98
616 APPLICATION SITE INFLAMMATION 98
617 FOETAL EXPOSURE DURING PREGNANCY 98
618 INCREASED APPETITE 98
619 NERVE INJURY 98
620 VULVOVAGINAL SWELLING 98
621 BREAST SWELLING 97
622 HYPERTHYROIDISM 97
623 RESPIRATORY DEPRESSION 97
624 TEMPERATURE INTOLERANCE 97
625 IRON DEFICIENCY ANAEMIA 96
626 BLOOD PRESSURE DIASTOLIC DECREASED 95
627 COLITIS ISCHAEMIC 94
628 DYSMENORRHOEA 94
629 ENDOMETRIOSIS 94
630 LABORATORY TEST ABNORMAL 94
631 POOR QUALITY DEVICE USED 94
632 BLOOD GLUCOSE DECREASED 93
633 HYPOPHAGIA 93
634 LARYNGITIS 93
635 MANIA 93
636 TOOTH FRACTURE 93
637 COORDINATION ABNORMAL 92
638 EXTRA DOSE ADMINISTERED 92
639 GLYCOSYLATED HAEMOGLOBIN INCREASED 92
640 NERVE COMPRESSION 92
641 OCULAR DISCOMFORT 92
642 RENAL FAILURE ACUTE 92
643 SPINAL DISORDER 92
644 VULVOVAGINAL ERYTHEMA 92
645 DEMENTIA 91
646 HAEMATURIA 91
647 HEPATOTOXICITY 91
648 INCONTINENCE 91
649 JOINT DISLOCATION 91
650 MUSCULOSKELETAL DISORDER 91
651 NIPPLE PAIN 91
652 PULMONARY MASS 91
653 SMALL INTESTINAL OBSTRUCTION 91
654 APHONIA 90
655 EYE INFECTION 90
656 UPPER-AIRWAY COUGH SYNDROME 90
657 APPLICATION SITE DISCOMFORT 89
658 BODY TEMPERATURE DECREASED 89
659 MACULOPATHY 89
660 MENOPAUSE 89
661 MENTAL STATUS CHANGES 89
662 ORAL CANDIDIASIS 89
663 ANHEDONIA 88
664 BLOOD PRESSURE SYSTOLIC ABNORMAL 88
665 DRY THROAT 88
666 HYPOAESTHESIA ORAL 88
667 QUALITY OF LIFE DECREASED 88
668 SCOLIOSIS 88
669 UTERINE HAEMORRHAGE 88
670 CARDIAC ARREST 87
671 CONCUSSION 87
672 EPILEPSY 87
673 GASTRIC ULCER 87
674 HIP ARTHROPLASTY 87
675 LIBIDO DECREASED 87
676 PRODUCT SOLUBILITY ABNORMAL 87
677 WEIGHT FLUCTUATION 87
678 CARDIAC FAILURE 86
679 FOOT DEFORMITY 86
680 LIVER FUNCTION TEST INCREASED 86
681 MUSCLE STRAIN 86
682 SKIN FISSURES 86
683 APPLICATION SITE DISCHARGE 85
684 EAR DISCOMFORT 85
685 HEMIPARESIS 85
686 INCREASED TENDENCY TO BRUISE 85
687 NEPHROGENIC ANAEMIA 85
688 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 85
689 SPINAL FRACTURE 85
690 TENDON RUPTURE 85
691 CHOLECYSTECTOMY 84
692 GASTROINTESTINAL PAIN 84
693 APPLICATION SITE EXFOLIATION 83
694 FACIAL PAIN 83
695 LOW DENSITY LIPOPROTEIN INCREASED 83
696 OSTEOMYELITIS 83
697 RHABDOMYOLYSIS 83
698 CONJUNCTIVITIS 82
699 HYPOXIA 82
700 IMPAIRED DRIVING ABILITY 82
701 MADAROSIS 82
702 OSTEONECROSIS OF JAW 82
703 PARANOIA 82
704 HUNGER 81
705 JOINT RANGE OF MOTION DECREASED 81
706 MASS 81
707 PRODUCT FORMULATION ISSUE 81
708 TUBULOINTERSTITIAL NEPHRITIS 81
709 ACCIDENTAL OVERDOSE 80
710 MALIGNANT NEOPLASM PROGRESSION 80
711 NOCTURIA 80
712 PRODUCT INEFFECTIVE 80
713 RENAL PAIN 80
714 SJOGREN^S SYNDROME 80
715 APPLICATION SITE HAEMORRHAGE 79
716 ATROPHIC VULVOVAGINITIS 79
717 BACK INJURY 79
718 INTERSTITIAL LUNG DISEASE 79
719 MENORRHAGIA 79
720 MITRAL VALVE INCOMPETENCE 79
721 ULCER 79
722 VITREOUS FLOATERS 79
723 FRUSTRATION TOLERANCE DECREASED 78
724 HAEMATOMA 78
725 HEPATITIS 78
726 OBESITY 78
727 PRODUCT DESIGN ISSUE 78
728 APPLICATION SITE DRYNESS 77
729 HYPOKINESIA 77
730 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 77
731 INITIAL INSOMNIA 77
732 SKIN HAEMORRHAGE 77
733 ANOSMIA 76
734 EYE DISCHARGE 76
735 LYMPHOCYTE COUNT DECREASED 76
736 OVARIAN HYPERSTIMULATION SYNDROME 76
737 PANCYTOPENIA 76
738 SPINAL STENOSIS 76
739 VENTRICULAR EXTRASYSTOLES 76
740 AFFECT LABILITY 75
741 APATHY 75
742 BLOOD IRON DECREASED 75
743 EYE HAEMORRHAGE 75
744 HAIR COLOUR CHANGES 75
745 HERNIA 75
746 IMMUNODEFICIENCY 75
747 PRODUCT PHYSICAL CONSISTENCY ISSUE 75
748 SECRETION DISCHARGE 75
749 SEDATION 75
750 ANAL INCONTINENCE 74
751 ENDOMETRIAL CANCER 74
752 FEBRILE NEUTROPENIA 74
753 FEELING DRUNK 74
754 HYPERAESTHESIA 74
755 MACULAR DEGENERATION 74
756 MUSCLE ATROPHY 74
757 THERMAL BURN 74
758 DEVICE DISLOCATION 73
759 NASAL POLYPS 73
760 NEUTROPHIL COUNT DECREASED 73
761 SEROTONIN SYNDROME 73
762 SQUAMOUS CELL CARCINOMA 73
763 BLOOD TEST ABNORMAL 72
764 HYPERGLYCAEMIA 72
765 INVASIVE DUCTAL BREAST CARCINOMA 72
766 PHARYNGEAL SWELLING 72
767 PHARYNGITIS 72
768 POST-TRAUMATIC STRESS DISORDER 72
769 SCAB 72
770 SKIN INFECTION 72
771 AFFECTIVE DISORDER 71
772 DENTAL CARIES 71
773 DIASTOLIC DYSFUNCTION 71
774 FLANK PAIN 71
775 HAEMOPTYSIS 71
776 HAIR DISORDER 71
777 HEAVY MENSTRUAL BLEEDING 71
778 PULMONARY HYPERTENSION 71
779 VISUAL FIELD DEFECT 71
780 C-REACTIVE PROTEIN ABNORMAL 70
781 ISCHAEMIC STROKE 70
782 VULVOVAGINAL INJURY 70
783 BLADDER PROLAPSE 69
784 DERMAL ABSORPTION IMPAIRED 69
785 EMBOLISM VENOUS 69
786 PRODUCT PACKAGING DIFFICULT TO OPEN 69
787 ANKYLOSING SPONDYLITIS 68
788 ASCITES 68
789 BLOOD CALCIUM INCREASED 68
790 GLUCOSE TOLERANCE IMPAIRED 68
791 LACERATION 68
792 MUSCLE SPASTICITY 68
793 NODULE 68
794 OBSTRUCTIVE AIRWAYS DISORDER 68
795 PLASMA CELL MYELOMA 68
796 TOOTH ABSCESS 68
797 BLOOD BILIRUBIN INCREASED 67
798 GINGIVAL BLEEDING 67
799 INTENTIONAL OVERDOSE 67
800 LIVER INJURY 67
801 PRODUCT TASTE ABNORMAL 67
802 PSYCHOMOTOR HYPERACTIVITY 67
803 SINUS TACHYCARDIA 67
804 BREAST CYST 66
805 DRUG EFFECT INCREASED 66
806 EYELID PTOSIS 66
807 PLATELET COUNT INCREASED 66
808 REBOUND ACID HYPERSECRETION 66
809 HYPERCHOLESTEROLAEMIA 65
810 MENSTRUAL DISORDER 65
811 PALLOR 65
812 PHARYNGITIS STREPTOCOCCAL 65
813 RHINITIS ALLERGIC 65
814 SCRATCH 65
815 SOMNAMBULISM 65
816 APPLICATION SITE EROSION 64
817 BLOOD CREATINE PHOSPHOKINASE INCREASED 64
818 CARDIAC FLUTTER 64
819 FEMALE GENITAL TRACT FISTULA 64
820 HEPATIC ENCEPHALOPATHY 64
821 TOOTH LOSS 64
822 APPLICATION SITE SCAB 63
823 ASTHENOPIA 63
824 CHOLECYSTITIS 63
825 DIZZINESS POSTURAL 63
826 HALLUCINATION, VISUAL 63
827 IMMUNE SYSTEM DISORDER 63
828 KNEE OPERATION 63
829 MALNUTRITION 63
830 MULTIPLE FRACTURES 63
831 ORTHOSTATIC HYPOTENSION 63
832 PRODUCT LABEL ISSUE 63
833 ACUTE MYOCARDIAL INFARCTION 62
834 BIPOLAR DISORDER 62
835 FORMICATION 62
836 GINGIVAL PAIN 62
837 NAIL DISORDER 62
838 PSYCHIATRIC SYMPTOM 62
839 TARDIVE DYSKINESIA 62
840 ADVERSE REACTION 61
841 DERMATITIS ALLERGIC 61
842 DRUG LEVEL DECREASED 61
843 INFUSION SITE HAEMORRHAGE 61
844 INJURY ASSOCIATED WITH DEVICE 61
845 INTENTIONAL DRUG MISUSE 61
846 MAJOR DEPRESSION 61
847 PERICARDITIS 61
848 PULMONARY THROMBOSIS 61
849 INFUSION SITE BRUISING 60
850 INFUSION SITE PRURITUS 60
851 MALIGNANT MELANOMA 60
852 NASAL DISCOMFORT 60
853 OSTEONECROSIS 60
854 PSYCHOLOGICAL TRAUMA 60
855 PULMONARY FIBROSIS 60
856 RESPIRATORY RATE INCREASED 60
857 RESPIRATORY SYMPTOM 60
858 RHINITIS 60
859 UTERINE POLYP 60
860 BACTERIAL VAGINOSIS 59
861 DRUG DISPENSING ERROR 59
862 FOOD ALLERGY 59
863 GLOMERULAR FILTRATION RATE DECREASED 59
864 GROIN PAIN 59
865 LUNG NEOPLASM MALIGNANT 59
866 PELVIC FRACTURE 59
867 POLYP 59
868 SPINAL COLUMN STENOSIS 59
869 THERAPY CHANGE 59
870 BLADDER PAIN 58
871 COMA 58
872 FIBROCYSTIC BREAST DISEASE 58
873 HAEMATEMESIS 58
874 HYPERKERATOSIS 58
875 LEUKOCYTOSIS 58
876 NASAL DRYNESS 58
877 PAROSMIA 58
878 PREMATURE BABY 58
879 SPINAL PAIN 58
880 SPUTUM INCREASED 58
881 ABSCESS 57
882 BLOOD THYROID STIMULATING HORMONE INCREASED 57
883 BREAST DISORDER 57
884 DEVICE USE ERROR 57
885 HEPATIC NECROSIS 57
886 METASTASES TO LYMPH NODES 57
887 PRODUCT COLOUR ISSUE 57
888 PRODUCT SUPPLY ISSUE 57
889 ROSACEA 57
890 SEPTIC SHOCK 57
891 SLUGGISHNESS 57
892 STRESS FRACTURE 57
893 ACUTE RESPIRATORY FAILURE 56
894 DELIRIUM 56
895 DRUG ERUPTION 56
896 FOREIGN BODY SENSATION IN EYES 56
897 HEPATIC FAILURE 56
898 INCORRECT ROUTE OF DRUG ADMINISTRATION 56
899 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 56
900 LIGAMENT RUPTURE 56
901 PRODUCT PREPARATION ERROR 56
902 SYNOVIAL CYST 56
903 ABNORMAL FAECES 55
904 CEREBRAL HAEMORRHAGE 55
905 CYSTOCELE 55
906 DEVICE MATERIAL ISSUE 55
907 FRACTURE 55
908 HALLUCINATION, AUDITORY 55
909 INCORRECT PRODUCT STORAGE 55
910 MASTECTOMY 55
911 PERICARDIAL EFFUSION 55
912 PNEUMONITIS 55
913 SKIN ABRASION 55
914 SPINAL COMPRESSION FRACTURE 55
915 UTERINE DISORDER 55
916 DECREASED ACTIVITY 54
917 DECREASED INTEREST 54
918 DRUG ABUSE 54
919 FOOT OPERATION 54
920 GENERALISED TONIC-CLONIC SEIZURE 54
921 HAND FRACTURE 54
922 HYPERCALCAEMIA 54
923 LYMPHOEDEMA 54
924 ONYCHOCLASIS 54
925 PARALYSIS 54
926 BLOOD UREA INCREASED 53
927 GASTROINTESTINAL INFECTION 53
928 HYPOCALCAEMIA 53
929 MENSTRUATION IRREGULAR 53
930 MIGRAINE WITH AURA 53
931 MUSCLE INJURY 53
932 POSTOPERATIVE WOUND INFECTION 53
933 SENSATION OF FOREIGN BODY 53
934 SINUSITIS FUNGAL 53
935 SKIN SWELLING 53
936 VAGINAL DISORDER 53
937 BLINDNESS UNILATERAL 52
938 BLOOD MAGNESIUM DECREASED 52
939 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52
940 GRIP STRENGTH DECREASED 52
941 NEUROLOGICAL SYMPTOM 52
942 OESOPHAGITIS 52
943 POOR QUALITY DRUG ADMINISTERED 52
944 RENAL CYST 52
945 SINUS HEADACHE 52
946 SKIN WARM 52
947 SPINAL FUSION SURGERY 52
948 SPUTUM DISCOLOURED 52
949 ADRENAL INSUFFICIENCY 51
950 ANAPHYLACTIC SHOCK 51
951 GOITRE 51
952 HELICOBACTER INFECTION 51
953 HYPERPARATHYROIDISM SECONDARY 51
954 PETECHIAE 51
955 RENAL TUBULAR NECROSIS 51
956 RETINAL VEIN OCCLUSION 51
957 SKIN ATROPHY 51
958 WOUND INFECTION 51
959 ATELECTASIS 50
960 BONE DENSITY ABNORMAL 50
961 CENTRAL NERVOUS SYSTEM LESION 50
962 COAGULOPATHY 50
963 DYSGRAPHIA 50
964 ENCEPHALOPATHY 50
965 FOLLICULITIS 50
966 GOUT 50
967 INTERVERTEBRAL DISC DISORDER 50
968 RAYNAUD^S PHENOMENON 50
969 SARS-COV-2 TEST POSITIVE 50
970 SUPRAVENTRICULAR TACHYCARDIA 50
971 BEDRIDDEN 49
972 BLOOD THYROID STIMULATING HORMONE DECREASED 49
973 BREAST DISCOMFORT 49
974 DEVICE RELATED INFECTION 49
975 DIABETIC KETOACIDOSIS 49
976 HERPES VIRUS INFECTION 49
977 INABILITY TO AFFORD MEDICATION 49
978 INJECTION SITE HAEMATOMA 49
979 LUNG INFECTION 49
980 MAMMOGRAM ABNORMAL 49
981 SUSPECTED PRODUCT QUALITY ISSUE 49
982 TOOTH EXTRACTION 49
983 TRANSAMINASES INCREASED 49
984 UTERINE CANCER 49
985 ANOREXIA 48
986 BLOOD CALCIUM DECREASED 48
987 BLOOD POTASSIUM INCREASED 48
988 BRUXISM 48
989 CARDIAC MURMUR 48
990 CARDIOMEGALY 48
991 DIARRHOEA HAEMORRHAGIC 48
992 HEPATOCELLULAR INJURY 48
993 HERPES SIMPLEX 48
994 INJECTION SITE INDURATION 48
995 MUSCLE DISORDER 48
996 MYDRIASIS 48
997 PARKINSON^S DISEASE 48
998 TENDON DISORDER 48
999 THERAPEUTIC RESPONSE CHANGED 48